Last reviewed · How we verify

Oximen® 3%

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Phase 1 active Small molecule

Oximen® 3% is a Small molecule drug developed by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana. It is currently in Phase 1 development. Also known as: H2O2, Hydrogen peroxide.

At a glance

Generic nameOximen® 3%
Also known asH2O2, Hydrogen peroxide
SponsorFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oximen® 3%

What is Oximen® 3%?

Oximen® 3% is a Small molecule drug developed by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana.

Who makes Oximen® 3%?

Oximen® 3% is developed by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (see full Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana pipeline at /company/fundaci-n-para-el-fomento-de-la-investigaci-n-sanitaria-y-biom-dica-de-la-comuni).

Is Oximen® 3% also known as anything else?

Oximen® 3% is also known as H2O2, Hydrogen peroxide.

What development phase is Oximen® 3% in?

Oximen® 3% is in Phase 1.

Related